VINC is no longer actively traded. Data shown reflects verified historical relationships.
1Suppliers
0Customers
1Debt Items
9Related Chains

Vincerx Pharma, Inc. Suppliers

TickerNameConfidenceEvidence
BAYER BAYER 90% given the approval by our board of directors of the Dissolution, it is expected that Bayer will terminate the License Agreement pursuant to its terms

Vincerx Pharma, Inc. Customers

No clients on recordNo downstream customers found in our database for Vincerx Pharma, Inc..

Vincerx Pharma, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
VINC-DEBT-13355 Warrants outstanding: 0.01 90% xbrl warrant detail from xbrl 2024-12-31.

Vincerx Pharma, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Vincerx Pharma, Inc..

Vincerx Pharma, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Vincerx Pharma, Inc..

Vincerx Pharma, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
BPTH Bio-Path Holdings, Inc. 100.00 2
LLY Eli Lilly and Company 100.00 2
STTK Shattuck Labs, Inc. 100.00 2
GILD Gilead Sciences, Inc. 100.00 2
NRIX Nurix Therapeutics, Inc. 100.00 2
RIGL Rigel Pharmaceuticals, Inc. 100.00 2
JNJ Johnson & Johnson 100.00 2
CRIS Curis, Inc. 36.29 1 ['spend']
ROCHE ROCHE 23.09 2